{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:50:28Z","timestamp":1793875828885,"version":"4.7.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Primary sclerosing cholangitis (PSC) is an idiopathic, progressive and incurable liver disease. Here, we aimed for systematic analyses of adaptive immune responses in PSC. By profiling the T\u2009cell repertoires of 504 individuals with PSC and 904 healthy controls, we identified 1,008 clonotypes associated with PSC. A substantial fraction of these clonotypes was restricted to known PSC human leukocyte antigen susceptibility alleles and known to target Epstein\u2013Barr virus (EBV) epitopes. We further utilized phage-immunoprecipitation sequencing to determine antibody epitope repertoires of 120 individuals with PSC and 202 healthy controls, which showed a higher burden of anti-EBV responses in PSC than controls. EBV-specific monoclonal antibodies isolated from B\u2009cells in PSC livers corroborated convergent B and T\u2009cell responses against EBV. By analyzing electronic health records of &gt;116\u2009million people, we identified an association between infectious mononucleosis and PSC (odds ratio, 12; 95% confidence interval, 6.3\u201322.9), suggesting a link between EBV and PSC.<\/jats:p>","DOI":"10.1038\/s41591-025-03692-w","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T05:03:52Z","timestamp":1749618232000},"page":"2306-2316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["T and B\u2009cell responses against Epstein\u2013Barr virus in primary sclerosing cholangitis"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1844-8279","authenticated-orcid":false,"given":"Hesham","family":"ElAbd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2066-7905","authenticated-orcid":false,"given":"Mitchell","family":"Pesesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Innocenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya K. H.","family":"Mahdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriia","family":"Kriukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Kulsvehagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Strobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"St\u00fchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6902-3153","authenticated-orcid":false,"given":"Damon H.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8208-1141","authenticated-orcid":false,"given":"Melanie","family":"Prinzensteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0125-1173","authenticated-orcid":false,"given":"Tim A.","family":"Steiert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3735-9872","authenticated-orcid":false,"given":"Florian","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6200-2675","authenticated-orcid":false,"given":"Michel V.","family":"Hadjihannas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2635-6422","authenticated-orcid":false,"given":"Elisa","family":"Rosati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1647-2526","authenticated-orcid":false,"given":"S\u00f6ren","family":"Mucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Lieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0919-0237","authenticated-orcid":false,"given":"Malte","family":"Ziemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2618-3920","authenticated-orcid":false,"given":"Astrid","family":"Dempfle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Folseraas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5900-8096","authenticated-orcid":false,"given":"Johannes R.","family":"Hov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6903-6878","authenticated-orcid":false,"given":"Espen","family":"Melum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Bacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Sterneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9736-1483","authenticated-orcid":false,"given":"Tobias J.","family":"Weism\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Lenzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Howie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlan S.","family":"Robins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6989-8002","authenticated-orcid":false,"given":"Christoph","family":"R\u00f6cken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2254-7771","authenticated-orcid":false,"given":"Stefan","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2642-419X","authenticated-orcid":false,"given":"Nina","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7748-1872","authenticated-orcid":false,"given":"Anne-Katrin","family":"Pr\u00f6bstel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4264-1928","authenticated-orcid":false,"given":"Christoph","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vogl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8289-9931","authenticated-orcid":false,"given":"Tom H.","family":"Karlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1530-5811","authenticated-orcid":false,"given":"Andre","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"3692_CR1","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen, T. H., Folseraas, T., Thorburn, D. & Vesterhus, M. Primary sclerosing cholangitis; a comprehensive review. J. Hepatol. 67, 1298\u20131323 (2017).","journal-title":"J. Hepatol."},{"key":"3692_CR2","doi-asserted-by":"publisher","first-page":"11729","DOI":"10.3389\/ti.2023.11729","volume":"36","author":"M Carbone","year":"2023","unstructured":"Carbone, M. et al. Liver transplantation for primary sclerosing cholangitis (PSC) with or without inflammatory bowel disease (IBD)\u2014a European Society of Organ Transplantation (ESOT) consensus statement. Transpl. Int. 36, 11729 (2023).","journal-title":"Transpl. Int."},{"key":"3692_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","volume":"77","author":"O Chazouilleres","year":"2022","unstructured":"Chazouilleres, O. et al. EASL clinical practice guidelines on sclerosing cholangitis. J. Hepatol. 77, 761\u2013806 (2022).","journal-title":"J. Hepatol."},{"key":"3692_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/liv.15471","volume":"43","author":"KN van Munster","year":"2023","unstructured":"van Munster, K. N. et al. Disease burden in primary sclerosing cholangitis in the Netherlands: a long-term follow-up study. Liver Int. 43, 639\u2013648 (2023).","journal-title":"Liver Int."},{"key":"3692_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng.3745","volume":"49","author":"S-G Ji","year":"2017","unstructured":"Ji, S.-G. et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat. Genet. 49, 269\u2013273 (2017).","journal-title":"Nat. Genet."},{"key":"3692_CR6","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ng.3528","volume":"48","author":"D Ellinghaus","year":"2016","unstructured":"Ellinghaus, D. et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat. Genet. 48, 510\u2013518 (2016).","journal-title":"Nat. Genet."},{"key":"3692_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ng.2616","volume":"45","author":"JZ Liu","year":"2013","unstructured":"Liu, J. Z. et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat. Genet. 45, 670\u2013675 (2013).","journal-title":"Nat. Genet."},{"key":"3692_CR8","doi-asserted-by":"publisher","first-page":"e114486","DOI":"10.1371\/journal.pone.0114486","volume":"9","author":"S N\u00e6ss","year":"2014","unstructured":"N\u00e6ss, S. et al. Refinement of the MHC risk map in a Scandinavian primary sclerosing cholangitis population. PLoS ONE 9, e114486 (2014).","journal-title":"PLoS ONE"},{"key":"3692_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/sj.gene.6364377","volume":"8","author":"TH Karlsen","year":"2007","unstructured":"Karlsen, T. H. et al. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Genes Immun. 8, 275\u2013278 (2007).","journal-title":"Genes Immun."},{"key":"3692_CR10","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.4049\/jimmunol.158.4.1941","volume":"158","author":"CS Probert","year":"1997","unstructured":"Probert, C. S. et al. Analysis of human common bile duct-associated T cells: evidence for oligoclonality, T cell clonal persistence, and epithelial cell recognition. J. Immunol. 158, 1941\u20131948 (1997).","journal-title":"J. Immunol."},{"key":"3692_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jhep.2021.03.016","volume":"75","author":"T Poch","year":"2021","unstructured":"Poch, T. et al. Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4+ T cells in primary sclerosing cholangitis. J. Hepatol. 75, 414\u2013423 (2021).","journal-title":"J. Hepatol."},{"key":"3692_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/gut.49.1.131","volume":"49","author":"X Bo","year":"2001","unstructured":"Bo, X., Broome, U., Remberger, M. & Sumitran-Holgersson, S. Tumour necrosis factor \u03b1 impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis. Gut 49, 131\u2013141 (2001).","journal-title":"Gut"},{"key":"3692_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/j.gastro.2014.04.003","volume":"147","author":"E Liaskou","year":"2014","unstructured":"Liaskou, E. et al. Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis. Gastroenterology 147, 221\u2013232.e7 (2014).","journal-title":"Gastroenterology"},{"key":"3692_CR14","doi-asserted-by":"publisher","unstructured":"Roth, D. B. V(D)J recombination: mechanism, errors, and fidelity. Microbiol. Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.MDNA3-0041-2014 (2014).","DOI":"10.1128\/microbiolspec.MDNA3-0041-2014"},{"key":"3692_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.coi.2013.09.017","volume":"25","author":"H Robins","year":"2013","unstructured":"Robins, H. Immunosequencing: applications of immune repertoire deep sequencing. Curr. Opin. Immunol. 25, 646\u2013652 (2013).","journal-title":"Curr. Opin. Immunol."},{"key":"3692_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3680","volume":"4","author":"CS Carlson","year":"2013","unstructured":"Carlson, C. S. et al. Using synthetic templates to design an unbiased multiplex PCR assay. Nat. Commun. 4, 2680 (2013).","journal-title":"Nat. Commun."},{"key":"3692_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/ng.3822","volume":"49","author":"RO Emerson","year":"2017","unstructured":"Emerson, R. O. et al. Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire. Nat. Genet. 49, 659\u2013665 (2017).","journal-title":"Nat. Genet."},{"key":"3692_CR18","doi-asserted-by":"publisher","unstructured":"Snyder, T. M. et al. Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1488860 (2025).","DOI":"10.3389\/fimmu.2024.1488860"},{"key":"3692_CR19","doi-asserted-by":"publisher","unstructured":"Greissl, J. et al. Immunosequencing of the T-cell receptor repertoire reveals signatures specific for identification and characterization of early Lyme disease. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2021.07.30.21261353 (2022).","DOI":"10.1101\/2021.07.30.21261353"},{"key":"3692_CR20","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/rheumatology\/kex517","volume":"57","author":"EA Komech","year":"2018","unstructured":"Komech, E. A. et al. CD8+ T cells with characteristic T cell receptor beta motif are detected in blood and expanded in synovial fluid of ankylosing spondylitis patients. Rheumatology 57, 1097\u20131104 (2018).","journal-title":"Rheumatology"},{"key":"3692_CR21","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/art.40028","volume":"69","author":"M Faham","year":"2017","unstructured":"Faham, M. et al. Discovery of T cell receptor \u03b2 motifs specific to HLA\u2013B27\u2013positive ankylosing spondylitis by deep repertoire sequence analysis. Arthritis Rheumatol. 69, 774\u2013784 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"3692_CR22","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1038\/s41591-023-02613-z","volume":"29","author":"OV Britanova","year":"2023","unstructured":"Britanova, O. V. et al. Targeted depletion of TRBV9+ T cells as immunotherapy in a patient with ankylosing spondylitis. Nat. Med. 29, 2731\u20132736 (2023).","journal-title":"Nat. Med."},{"key":"3692_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nbt.1856","volume":"29","author":"HB Larman","year":"2011","unstructured":"Larman, H. B. et al. Autoantigen discovery with a synthetic human peptidome. Nat. Biotechnol. 29, 535\u2013541 (2011).","journal-title":"Nat. Biotechnol."},{"key":"3692_CR24","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1038\/s41596-018-0025-6","volume":"13","author":"D Mohan","year":"2018","unstructured":"Mohan, D. et al. PhIP\u2013seq characterization of serum antibodies using oligonucleotide-encoded peptidomes. Nat. Protoc. 13, 1958\u20131978 (2018).","journal-title":"Nat. Protoc."},{"key":"3692_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/ibd\/izab071","volume":"28","author":"LE Raffals","year":"2022","unstructured":"Raffals, L. E. et al. The development and initial findings of a study of a prospective adult research cohort with inflammatory bowel disease (SPARC IBD). Inflamm. Bowel Dis. 28, 192\u2013199 (2022).","journal-title":"Inflamm. Bowel Dis."},{"key":"3692_CR26","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/hep.28116","volume":"63","author":"E Liaskou","year":"2016","unstructured":"Liaskou, E. et al. High\u2010throughput T\u2010cell receptor sequencing across chronic liver diseases reveals distinct disease\u2010associated repertoires. Hepatology 63, 1608\u201319 (2016).","journal-title":"Hepatology"},{"key":"3692_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jhep.2016.09.002","volume":"66","author":"EKK Henriksen","year":"2017","unstructured":"Henriksen, E. K. K. et al. Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease. J. Hepatol. 66, 116\u2013122 (2017).","journal-title":"J. Hepatol."},{"key":"3692_CR28","doi-asserted-by":"publisher","unstructured":"Zahid, H. J. et al. Large-scale statistical mapping of T-cell receptor \u03b2 sequences to human leukocyte antigens. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.04.01.587617 (2024).","DOI":"10.1101\/2024.04.01.587617"},{"key":"3692_CR29","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41592-022-01578-0","volume":"19","author":"M Goncharov","year":"2022","unstructured":"Goncharov, M. et al. VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2. Nat. Methods 19, 1017\u20131019 (2022).","journal-title":"Nat. Methods"},{"key":"3692_CR30","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1093\/bioinformatics\/btx286","volume":"33","author":"N Tickotsky","year":"2017","unstructured":"Tickotsky, N., Sagiv, T., Prilusky, J., Shifrut, E. & Friedman, N. McPAS-TCR: a manually curated catalogue of pathology-associated T cell receptor sequences. Bioinformatics 33, 2924\u20132929 (2017).","journal-title":"Bioinformatics"},{"key":"3692_CR31","doi-asserted-by":"publisher","first-page":"e0141561","DOI":"10.1371\/journal.pone.0141561","volume":"10","author":"M Klinger","year":"2015","unstructured":"Klinger, M. et al. Multiplex identification of antigen-specific T cell receptors using a combination of immune assays and immune receptor sequencing. PLoS ONE 10, e0141561 (2015).","journal-title":"PLoS ONE"},{"key":"3692_CR32","doi-asserted-by":"publisher","unstructured":"May, D. H. et al. Identifying immune signatures of common exposures through co-occurrence of T-cell receptors in tens of thousands of donors. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.03.26.583354 (2024).","DOI":"10.1101\/2024.03.26.583354"},{"key":"3692_CR33","doi-asserted-by":"publisher","unstructured":"Pesesky, M. et al. Antigen-driven expansion of public clonal T cell populations in inflammatory bowel diseases. J. Crohns Colitis https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaf048 (2025).","DOI":"10.1093\/ecco-jcc\/jjaf048"},{"key":"3692_CR34","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.immuni.2023.04.003","volume":"56","author":"S Andreu-S\u00e1nchez","year":"2023","unstructured":"Andreu-S\u00e1nchez, S. et al. Phage display sequencing reveals that genetic, environmental, and intrinsic factors influence variation of human antibody epitope repertoire. Immunity 56, 1376\u20131392.e8 (2023).","journal-title":"Immunity"},{"key":"3692_CR35","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/s41591-021-01409-3","volume":"27","author":"T Vogl","year":"2021","unstructured":"Vogl, T. et al. Population-wide diversity and stability of serum antibody epitope repertoires against human microbiota. Nat. Med. 27, 1442\u20131450 (2021).","journal-title":"Nat. Med."},{"key":"3692_CR36","doi-asserted-by":"publisher","first-page":"eabq2422","DOI":"10.1126\/sciadv.abq2422","volume":"8","author":"T Vogl","year":"2024","unstructured":"Vogl, T. et al. Systemic antibody responses against human microbiota flagellins are overrepresented in chronic fatigue syndrome patients. Sci. Adv. 8, eabq2422 (2024).","journal-title":"Sci. Adv."},{"key":"3692_CR37","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.immuni.2023.04.017","volume":"56","author":"AR Bourgonje","year":"2023","unstructured":"Bourgonje, A. R. et al. Phage-display immunoprecipitation sequencing of the antibody epitope repertoire in inflammatory bowel disease reveals distinct antibody signatures. Immunity 56, 1393\u20131409.e6 (2023).","journal-title":"Immunity"},{"key":"3692_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jneuroim.2017.07.013","volume":"310","author":"JW Lindsey","year":"2017","unstructured":"Lindsey, J. W. Antibodies to the Epstein-Barr virus proteins BFRF3 and BRRF2 cross-react with human proteins. J. Neuroimmunol. 310, 131\u2013134 (2017).","journal-title":"J. Neuroimmunol."},{"key":"3692_CR39","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/art.41994","volume":"74","author":"S Fechtner","year":"2022","unstructured":"Fechtner, S. et al. Antibody responses to Epstein\u2013Barr virus in the preclinical period of rheumatoid arthritis suggest the presence of increased viral reactivation cycles. Arthritis Rheumatol. 74, 597\u2013603 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"3692_CR40","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","volume":"286","author":"A Ascherio","year":"2001","unstructured":"Ascherio, A. et al. Epstein\u2013Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286, 3083\u20133088 (2001).","journal-title":"JAMA"},{"key":"3692_CR41","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00296-012-2504-3","volume":"33","author":"SG Pasoto","year":"2013","unstructured":"Pasoto, S. G. et al. EBV reactivation serological profile in primary Sj\u00f6gren\u2019s syndrome: an underlying trigger of active articular involvement? Rheumatol. Int. 33, 1149\u20131157 (2013).","journal-title":"Rheumatol. Int."},{"key":"3692_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2174\/1573396320666230801091558","volume":"20","author":"AKC Leung","year":"2024","unstructured":"Leung, A. K. C. et al. Infectious mononucleosis: an updated review. Curr. Pediatr. Rev. 20, 305\u2013322 (2024).","journal-title":"Curr. Pediatr. Rev."},{"key":"3692_CR43","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41584-024-01167-9","volume":"20","author":"WH Robinson","year":"2024","unstructured":"Robinson, W. H., Younis, S., Love, Z. Z., Steinman, L. & Lanz, T. V. Epstein\u2013Barr virus as a potentiator of autoimmune diseases. Nat. Rev. Rheumatol. 20, 729\u2013740 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"3692_CR44","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein\u2013Barr virus associated with multiple sclerosis. Science 375, 296\u2013301 (2022).","journal-title":"Science"},{"key":"3692_CR45","doi-asserted-by":"publisher","first-page":"R295","DOI":"10.1186\/ar1181","volume":"6","author":"UY Moon","year":"2004","unstructured":"Moon, U. Y. et al. Patients with systemic lupus erythematosus have abnormally elevated Epstein\u2013Barr virus load in blood. Arthritis Res. Ther. 6, R295 (2004).","journal-title":"Arthritis Res. Ther."},{"key":"3692_CR46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0306-9877(87)90033-8","volume":"22","author":"S Whittingham","year":"1987","unstructured":"Whittingham, S., McNeilage, L. J. & Mackay, I. R. Epstein\u2013Barr virus as an etiological agent in primary Sj\u00f6gren\u2019s syndrome. Med. Hypotheses 22, 373\u2013386 (1987).","journal-title":"Med. Hypotheses"},{"key":"3692_CR47","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1136\/annrheumdis-2019-215361","volume":"78","author":"NR Jog","year":"2019","unstructured":"Jog, N. R. et al. Association of Epstein\u2013Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Ann. Rheum. Dis. 78, 1235 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"3692_CR48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nm1167","volume":"11","author":"MT McClain","year":"2005","unstructured":"McClain, M. T. et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat. Med. 11, 85\u201389 (2005).","journal-title":"Nat. Med."},{"key":"3692_CR49","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.3389\/fimmu.2019.02619","volume":"10","author":"K Csorba","year":"2019","unstructured":"Csorba, K. et al. Anti-C1q antibodies as occurring in systemic lupus erythematosus could be induced by an Epstein\u2013Barr virus-derived antigenic site. Front. Immunol. 10, 2619 (2019).","journal-title":"Front. Immunol."},{"key":"3692_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz, T. V. et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321\u2013327 (2022).","journal-title":"Nature"},{"key":"3692_CR51","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S1074-7613(01)00226-6","volume":"15","author":"TE Morrison","year":"2001","unstructured":"Morrison, T. E., Mauser, A., Wong, A., Ting, J. P.-Y. & Kenney, S. C. Inhibition of IFN-\u03b3 signaling by an Epstein\u2013Barr virus immediate-early protein. Immunity 15, 787\u2013799 (2001).","journal-title":"Immunity"},{"key":"3692_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/rmv.441","volume":"15","author":"T Tsurumi","year":"2005","unstructured":"Tsurumi, T., Fujita, M. & Kudoh, A. Latent and lytic Epstein\u2013Barr virus replication strategies. Rev. Med. Virol. 15, 3\u201315 (2005).","journal-title":"Rev. Med. Virol."},{"key":"3692_CR53","doi-asserted-by":"publisher","first-page":"e01070-19","DOI":"10.1128\/JVI.01070-19","volume":"93","author":"SG Salamun","year":"2019","unstructured":"Salamun, S. G. et al. The Epstein\u2013Barr virus BMRF1 protein activates transcription and inhibits the DNA damage response by binding NuRD. J. Virol. 93, e01070-19 (2019).","journal-title":"J. Virol."},{"key":"3692_CR54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7205\/MILMED-D-14-00739","volume":"180","author":"CL Perdue","year":"2015","unstructured":"Perdue, C. L., Eick-Cost, A. A. & Rubertone, M. V. A brief description of the operation of the DoD serum repository. Mil. Med. 180, 10\u201312 (2015).","journal-title":"Mil. Med."},{"key":"3692_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52195-8","volume":"15","author":"AC Ebert","year":"2024","unstructured":"Ebert, A. C. et al. Risk of inflammatory bowel disease following hospitalisation with infectious mononucleosis: nationwide cohort study from Denmark. Nat. Commun. 15, 8383 (2024).","journal-title":"Nat. Commun."},{"key":"3692_CR56","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41564-020-0758-1","volume":"5","author":"W Liu","year":"2020","unstructured":"Liu, W. et al. Structures of capsid and capsid-associated tegument complex inside the Epstein\u2013Barr virus. Nat. Microbiol. 5, 1285\u20131298 (2020).","journal-title":"Nat. Microbiol."},{"key":"3692_CR57","doi-asserted-by":"publisher","first-page":"e151849","DOI":"10.1172\/jci.insight.151849","volume":"7","author":"RM Gittelman","year":"2022","unstructured":"Gittelman, R. M. et al. Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection. JCI Insight 7, e151849 (2022).","journal-title":"JCI Insight"},{"key":"3692_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s43018-019-0019-5","volume":"1","author":"W Pruessmann","year":"2020","unstructured":"Pruessmann, W. et al. Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence. Nat. Cancer 1, 197\u2013209 (2020).","journal-title":"Nat. Cancer"},{"key":"3692_CR59","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/hmg\/ddy443","volume":"28","author":"F Degenhardt","year":"2019","unstructured":"Degenhardt, F. et al. Construction and benchmarking of a multi-ethnic reference panel for the imputation of HLA class I and II alleles. Hum. Mol. Genet. 28, 2078\u20132092 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"3692_CR60","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/hmg\/ddab017","volume":"30","author":"F Degenhardt","year":"2021","unstructured":"Degenhardt, F. et al. Trans-ethnic analysis of the human leukocyte antigen region for ulcerative colitis reveals shared but also ethnicity-specific disease associations. Hum. Mol. Genet. 30, 356\u2013369 (2021).","journal-title":"Hum. Mol. Genet."},{"key":"3692_CR61","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nmeth.3364","volume":"12","author":"DA Bolotin","year":"2015","unstructured":"Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380\u2013381 (2015).","journal-title":"Nat. Methods"},{"key":"3692_CR62","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1016\/j.immuni.2022.11.004","volume":"55","author":"S Leviatan","year":"2022","unstructured":"Leviatan, S. et al. Allergenic food protein consumption is associated with systemic IgG antibody responses in non-allergic individuals. Immunity 55, 2454\u20132469.e6 (2022).","journal-title":"Immunity"},{"key":"3692_CR63","doi-asserted-by":"publisher","first-page":"eabe9950","DOI":"10.1126\/sciimmunol.abe9950","volume":"6","author":"S Klompus","year":"2021","unstructured":"Klompus, S. et al. Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers. Sci. Immunol. 6, eabe9950 (2021).","journal-title":"Sci. Immunol."},{"key":"3692_CR64","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaut.2016.10.003","volume":"77","author":"BK Chung","year":"2017","unstructured":"Chung, B. K. et al. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis. J. Autoimmun. 77, 45\u201354 (2017).","journal-title":"J. Autoimmun."},{"key":"3692_CR65","doi-asserted-by":"publisher","unstructured":"ElAbd, H. et al. The TRB repertoires for ElAbd et al.; 2025; Nat Med. Zenodo https:\/\/doi.org\/10.5281\/zenodo.14989127 (2025).","DOI":"10.5281\/zenodo.14989127"},{"key":"3692_CR66","doi-asserted-by":"publisher","unstructured":"ElAbd, H. et al. The PhIP-Seq repertoires of the 120 individuals with PSC from ElAbd et al.; 2025; Nat Med manuscript. Zenodo https:\/\/doi.org\/10.5281\/zenodo.14989837 (2025).","DOI":"10.5281\/zenodo.14989837"},{"key":"3692_CR67","doi-asserted-by":"publisher","unstructured":"ElAbd, H. et al. The PhIP-Seq repertoires of the 202 healthy controls from ElAbd et al.; 2025; Nat Med manuscript. Zenodo https:\/\/doi.org\/10.5281\/zenodo.14989788 (2025).","DOI":"10.5281\/zenodo.14989788"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03692-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03692-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03692-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T18:55:06Z","timestamp":1757184906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03692-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["3692"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-03692-w","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"17 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.P., D.H.M., B.H. and H.S.R. have or had employment and equity ownership with Adaptive Biotechnologies. H.E. did an internship at Adaptive biotechnologies from July 2023 until September 2023. F.T. received speaker\u2019s fees from Abbvie, Bristol-Myers-Squibb, Celltrion Healthcare, Dr Falk Pharma, Eli Lilly, Ferring Pharmaceuticals and Janssen, and funding from Sanofi\/Regeneron. T.H.K. declares consulting fees from Albireo, Boehringer Ingelheim, MSD, Gilead and Falk Pharma unrelated to the present work. A.-K.P. (institution) has received speaker, consulting or travel honoraria from Novartis, Biogen, Roche and UCB all used for research support and unrelated to the present work. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}